NCT04665700View on ClinicalTrials.gov

A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

February 6, 2021

Primary Completion Date

October 16, 2021

Study Completion Date

October 16, 2021

Conditions
Healthy
Interventions
DRUG

BI 764198

BI 764198

DRUG

Placebo

Placebo

Trial Locations (1)

130-0004

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04665700 - A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated | Biotech Hunter | Biotech Hunter